Abstract | OBJECTIVES: BACKGROUND: The evidence of long-term efficacy and safety after implantation of DES in patients with complex lesions is scarce. METHODS: RESULTS: At 3 years, target lesion revascularization was 6.1% in the DES group compared with 16.3% in the BMS group (p<0.001), and the rate of major adverse cardiac events was 11.5% versus 18.2%, respectively (p=0.02). Whereas all-cause mortality did not differ significantly, the rate of cardiac death was higher in the DES group, 6.1% versus 1.9% for the BMS group (p=0.01). The occurrence of reinfarction, stroke, and stent thrombosis was similar. CONCLUSIONS:
|
Authors | Anne Kaltoft, Henning Kelbaek, Leif Thuesen, Jens Flensted Lassen, Peter Clemmensen, Lene Kløvgaard, Thomas Engstrøm, Hans E Bøtker, Kari Saunamäki, Lars R Krusell, Erik Jørgensen, Hans-Henrik Tilsted, Evald H Christiansen, Jan Ravkilde, Lars Køber, Klaus F Kofoed, Christian J Terkelsen, Steffen Helqvist |
Journal | Journal of the American College of Cardiology
(J Am Coll Cardiol)
Vol. 56
Issue 8
Pg. 641-5
(Aug 17 2010)
ISSN: 1558-3597 [Electronic] United States |
PMID | 20688033
(Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Topics |
- Angioplasty, Balloon
- Drug-Eluting Stents
(adverse effects)
- Electrocardiography
- Female
- Follow-Up Studies
- Humans
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Myocardial Infarction
(mortality, physiopathology, therapy)
- Stents
(adverse effects)
- Survival Rate
- Thrombosis
(etiology)
|